BIOMARIN PHARMACEUTICAL INC Investments, Fair Value Disclosure
BIOMARIN PHARMACEUTICAL INC (BMRN) had Investments, Fair Value Disclosure of $4.10 million as of 2016-12-31, per its 10-Q filed 2017-10-31.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:InvestmentsFairValueDisclosure · last filed 2017-10-31
- 2016-12-31: Investments, Fair Value Disclosure $4.10M.
- 2016-09-30: Investments, Fair Value Disclosure $7.30M.
- 2016-06-30: Investments, Fair Value Disclosure $4.70M.
- 2016-03-31: Investments, Fair Value Disclosure $8.10M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2016-12-31 | $4.10M 10-Q · filed 2017-10-31 |
| 2016-09-30 | $7.30M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $4.70M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $8.10M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $18.10M 10-K · filed 2017-02-27 |
| 2015-09-30 | $21.40M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $30.10M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $41.80M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $30.80M 10-K · filed 2016-02-29 |
| 2013-12-31 | $13.00M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |